Chemomab Therapeutics Ltd. (CMMB)

$ 8.43
-0.82 (-8.86%)
-
Symbol CMMB
Price $ 8.43
Beta 0.000
Volume Avg. 0.14M
Market Cap 0.096B
Shares () -
52 Week Range 8.03-168.8
1y Target Est -
DCF Unlevered CMMB DCF ->
DCF Levered CMMB LDCF ->
ROE -19.94% Sell
ROA -14.21% Sell
Operating Margin -
Debt / Equity 2.94% Neutral
P/E -
P/B 1.47 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CMMB news


Dr. Frank G. Haluska
Healthcare
Biotechnology
Nasdaq Capital Market

Anchiano Therapeutics Ltd, formerly known as ABioCancell Therapeutics Inc, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search and destroys paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.